TIMP3 and lung carcinoma: Clinical studies have shown that TIMP‐3 expression is decreased in many cancer types, and decreased expression of TIMP‐3 is significantly associated with pathologic stage, nodal involvement, and poor survival in lung cancer patients.8, 9